These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 14747848)

  • 21. [The chronic complications of diabetes].
    Sanmartín EF
    Rev Enferm; 1990 May; 13(141 Suppl):14-8. PubMed ID: 2359931
    [No Abstract]   [Full Text] [Related]  

  • 22. New hope for the treatment of diabetic complications.
    Corder R
    Clin Sci (Lond); 2002 Sep; 103(3):323-4. PubMed ID: 12193158
    [No Abstract]   [Full Text] [Related]  

  • 23. The Protein Kinase C Inhibitor: Ruboxistaurin.
    Deissler HL; Lang GE
    Dev Ophthalmol; 2016; 55():295-301. PubMed ID: 26501476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Potential pharmacological treatments for diabetic retinopathy].
    Watanabe D; Takagi H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():244-9. PubMed ID: 15999714
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diabetes mellitus. Metabolic, vascular, neurologic and infectious complications].
    Guillausseau PJ; Guillausseau-Scholer C
    Soins; 1989 May; (524):8-14. PubMed ID: 2749315
    [No Abstract]   [Full Text] [Related]  

  • 26. [Development of therapeutic agents for diabetic neuropathies].
    Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():614-21. PubMed ID: 15999780
    [No Abstract]   [Full Text] [Related]  

  • 27. Ruboxistaurin: PKC-beta inhibition for complications of diabetes.
    Danis RP; Sheetz MJ
    Expert Opin Pharmacother; 2009 Dec; 10(17):2913-25. PubMed ID: 19929710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapies for diabetic retinopathy: present and future.
    Schwartz SG; Flynn HW
    Exp Diabetes Res; 2007; 2007():52487. PubMed ID: 17713597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic retinopathy with protein kinase C subtype Beta inhibitor.
    Lang GE
    Dev Ophthalmol; 2007; 39():157-165. PubMed ID: 17245085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ruboxistaurin on nephropathy in type 2 diabetes.
    Tuttle KR; Bakris GL; Toto RD; McGill JB; Hu K; Anderson PW
    Diabetes Care; 2005 Nov; 28(11):2686-90. PubMed ID: 16249540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of aldose reductase inhibitors in diabetic complications: recent trends.
    Kaul CL; Ramarao P
    Methods Find Exp Clin Pharmacol; 2001 Oct; 23(8):465-75. PubMed ID: 11838322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology of diabetic complications.
    Altan VM
    Curr Med Chem; 2003 Aug; 10(15):1317-27. PubMed ID: 12871132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus--overview.
    Hoogwerf BJ; Sferra J; Donley BG
    Foot Ankle Clin; 2006 Dec; 11(4):703-15. PubMed ID: 17097511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study.
    Cherney DZ; Konvalinka A; Zinman B; Diamandis EP; Soosaipillai A; Reich H; Lorraine J; Lai V; Scholey JW; Miller JA
    Diabetes Care; 2009 Jan; 32(1):91-3. PubMed ID: 18945921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Late complications of diabetes mellitus type II (non-insulin- dependent)].
    Czech A
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():23-8. PubMed ID: 8516200
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of ruboxistaurin on albuminuria and estimated GFR in people with diabetic peripheral neuropathy: results from a randomized trial.
    Tuttle KR; McGill JB; Bastyr EJ; Poi KK; Shahri N; Anderson PW
    Am J Kidney Dis; 2015 Apr; 65(4):634-6. PubMed ID: 25618186
    [No Abstract]   [Full Text] [Related]  

  • 37. Rubosixtaurin and other PKC inhibitors in diabetic retinopathy and macular edema. Review.
    Gálvez MI
    Curr Diabetes Rev; 2009 Feb; 5(1):14-7. PubMed ID: 19199893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of diabetic complications despite the absence of growth hormone in a patient with post-pancreatectomy diabetes.
    Rabin D; Bloomgarden ZT; Feman SS; Davis TQ
    N Engl J Med; 1984 Mar; 310(13):837-9. PubMed ID: 6700672
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.
    Donnelly R; Idris I; Forrester JV
    Br J Ophthalmol; 2004 Jan; 88(1):145-51. PubMed ID: 14693793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New hope for ending complications. Working together to protect your body from diabetes damage.
    Gebel E
    Diabetes Forecast; 2012 Apr; 65(4):56, 59-60. PubMed ID: 22582527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.